Effect of BPC 157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study [Edwin Lee](https: pubmed.ncbi.nlm.nih.gov ?term=Lee+E&cauthor_id=39325560), [Christopher Walker](https: pubmed.ncbi.nlm.nih.gov ?term=Walker+C&cauthor_id=39325560 Secondary Analysis of Interstitial Cystitis Bladder Pain Syndrome Patients Enrolled in a Recurrent Urinary Tract Infection Prevention Study Provides a Novel Paradigm for Etio Pathogenesis and Practical Management of This Infection Phenotype Novel Treatment for Interstitial Cystitis Pilot Study BPC 157: Miracle Healing Peptide or Hidden Danger? BPC 157 and the Difference Between an Evidence Gap and a Cover Up: What the entire human evidence base actually looks like, and the questions to ask next. WellFounded Founders Health & Frontiers Pain Management in a Model of Interstitial Cystitis Bladder Pain Syndrome by a Vaccinal Strategy